Skip to content

13F-HR filed by Euclidean Capital LLC

Euclidean Capital LLC filed this 13F-HR for the quarter ended 2025-06-30, filed 2025-08-14, with 11 holding rows worth $305,720,149.

Accession
0001012975-25-000445
Filed
2025-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2025

A holdings report, 11 entries on the cover page, a total value of $305,720,149 stated on the cover page (in dollars after the unit check, H1), rows summing to $305,720,149 with VALUE read as dollars as filed, 13F file number 028-20777. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Vanguard FTSE All-World ex-US ETF922042775SHS2,142,684$144,031,218dollars as filed
ISHARES TR46429B598MSCI INDIA ETF2,425,144$135,032,018dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM989,410$10,042,512dollars as filed
FOGHORN THERAPEUTICS INC344174107COMMON STOCK1,573,761$7,396,677dollars as filed
PMV PHARMACEUTICALS INC69353Y103COM2,627,643$2,785,302dollars as filed
SPY78462F103SHS4,104$2,535,656dollars as filed
ALECTOR INC014442107COMMON STOCK1,307,858$1,831,001dollars as filed
SURROZEN INC86889P208COMMON STOCK87,696$784,002dollars as filed
RAPT THERAPEUTICS INC75382E208COM NEW82,234$657,872dollars as filed
TENAYA THERAPEUTICS INC87990A106COM1,015,705$620,799dollars as filed
SURROZEN INC86889P117*W EXP 08/01/203170,833$3,092dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001012975-25-000445this filing2025-08-14acceptance time not in the bulk data set